WO2004039839A3 - Modified voltage-gated calcium channels - Google Patents
Modified voltage-gated calcium channels Download PDFInfo
- Publication number
- WO2004039839A3 WO2004039839A3 PCT/EP2003/008938 EP0308938W WO2004039839A3 WO 2004039839 A3 WO2004039839 A3 WO 2004039839A3 EP 0308938 W EP0308938 W EP 0308938W WO 2004039839 A3 WO2004039839 A3 WO 2004039839A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cav
- channels
- modified
- gated calcium
- calcium channels
- Prior art date
Links
- 102000038650 voltage-gated calcium channel activity Human genes 0.000 title 1
- 108091023044 voltage-gated calcium channel activity Proteins 0.000 title 1
- 108091006146 Channels Proteins 0.000 abstract 8
- 238000000034 method Methods 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 102000034573 Channels Human genes 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003281999A AU2003281999A1 (en) | 2002-10-31 | 2003-08-12 | Modified voltage-gated calcium channels |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10252213.8 | 2002-10-31 | ||
DE10252213 | 2002-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004039839A2 WO2004039839A2 (en) | 2004-05-13 |
WO2004039839A3 true WO2004039839A3 (en) | 2004-06-24 |
Family
ID=32185420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/008938 WO2004039839A2 (en) | 2002-10-31 | 2003-08-12 | Modified voltage-gated calcium channels |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003281999A1 (en) |
WO (1) | WO2004039839A2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6441156B1 (en) * | 1998-12-30 | 2002-08-27 | The United States Of America As Represented By The Department Of Health And Human Services | Calcium channel compositions and methods of use thereof |
-
2003
- 2003-08-12 AU AU2003281999A patent/AU2003281999A1/en not_active Abandoned
- 2003-08-12 WO PCT/EP2003/008938 patent/WO2004039839A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6441156B1 (en) * | 1998-12-30 | 2002-08-27 | The United States Of America As Represented By The Department Of Health And Human Services | Calcium channel compositions and methods of use thereof |
Non-Patent Citations (6)
Title |
---|
32ND ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE, 6 November 2002 (2002-11-06), pages abs No 619.3, XP001180943 * |
DATABASE EMBL [online] 12 September 2001 (2001-09-12), XP002277629, Database accession no. AF247141 * |
DATABASE EMBL [online] 21 April 2002 (2002-04-21), XP002277628, Database accession no. AL731803 * |
DATABASE EMBL [online] 21 February 2002 (2002-02-21), XP002277627, Database accession no. AL672219 * |
DATABASE EMBL [online] 8 January 2001 (2001-01-08), XP002277630, Database accession no. AF247139 * |
THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 279, no. 8, 20 February 2004 (2004-02-20), pages 7322 - 7330, XP001180843 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004039839A2 (en) | 2004-05-13 |
AU2003281999A1 (en) | 2004-05-25 |
AU2003281999A8 (en) | 2004-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002083945A3 (en) | Diagnosis and treatment of cancer: i | |
WO2006044748A3 (en) | RESPONSE PREDICTORS FOR ErbB PATHWAY-SPECIFIC DRUGS | |
EP1629084A4 (en) | Modulation of c-reactive protein expression | |
AU2002952548A0 (en) | Diagnostic assay | |
WO2007053245A3 (en) | Methods and composition to generate unique sequence dna probes, iabeling of dna probes and the use of these probes | |
WO2000027994A3 (en) | Chlamydia pneumoniae genome sequence | |
WO2002010750A3 (en) | Biosensors, reagents and diagnostic applications of directed evolution | |
WO2005007814A3 (en) | Genome mapping of functional dna elements and cellular proteins | |
WO2005121374A3 (en) | Molecular analysis of hair follicles for disease | |
WO2005067648A3 (en) | Multiplex spatial profiling of gene expression | |
WO2002063271A8 (en) | Activity based probe analysis | |
WO2005000335A3 (en) | Use of genes differentially expressed during aging of liver for treatment and diagnosis | |
DK1232260T3 (en) | Polymorphism in the human MDR-1 gene and applications thereof | |
WO2004048522A3 (en) | Modulation of huntingtin interacting protein 2 expression | |
WO2004094476A3 (en) | Compositions and methods relating to stop-1 | |
WO2003078603A3 (en) | Strong gene sets for glioma classification | |
WO2004113574A3 (en) | Methods for disease screening | |
WO2001020026A3 (en) | POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | |
WO2000008157A3 (en) | Human anion transporter genes atnov | |
WO2004043394A3 (en) | Modulation of huntingtin interacting protein 1 expression | |
WO2004039839A3 (en) | Modified voltage-gated calcium channels | |
AU3205600A (en) | Method and kit for early cancer prediction | |
WO2005017102A3 (en) | Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins | |
WO2004013311A3 (en) | Compositions and methods relating to ovarian specific genes and proteins | |
WO2003093501A3 (en) | Ssh based methods for identifying and isolating unique nucleic acid sequences |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |